Multi-targeted type 2 diabetes therapy (Numerate)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMulti-targeted type 2 diabetes therapy (Numerate)
Drug Alias NameMTT2DT (Numerate)dual-targeted HMG-CoA reductase/p38a MAPK inhibitors (Numerate)MTT2DT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitorsP38 α mitogen-activated protein kinase inhibitors
TargetsHMG-CoA reductaseP38 α mitogen-activated protein kinase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Cardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmix Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmix CorpNumerate Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Cardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A